Compare 10X Genomics Inc (TXG) vs Zoom Video Communications, Inc. (ZM) Price & Performance

TXG trades at $47.20, up 7.91% on the day, with a bullish technical signal from moving averages. The company reported Q1 2026 revenue that beat estimates, and net losses have narrowed significantly from -$255M in 2023 to -$44M in 2025. Operating cash flow turned strongly positive at $136M in 2025. Recent developments include the acquisition of Proteintech Genomics and a collaboration with Cleveland Clinic on bladder cancer diagnostics.

The outlook is mixed; improving fundamentals and strategic expansions support growth, but persistent net losses and a high EV/EBITDA of 133.91 pose valuation risks. Analyst consensus is divided with a $39.14 price target below the current price, indicating caution despite a majority buy/hold ratings.

Zoom Communications (ZM) trades at $89.77, down 1.49% on the day, with a bullish technical signal supported by moving averages. The company maintains strong profitability with 77.4% gross margins and 42% net income margins, while recent AI-focused acquisitions and APAC leadership appointments signal growth initiatives. Q1 2026 earnings beat expectations with $1.55 EPS versus $1.42 expected.

Investment outlook remains positive with a $118.79 consensus price target offering 32% upside potential, though risks include competitive pressure from Microsoft and Google, insider selling activity, and fluctuating cash flow trends. Wall Street sentiment is mixed with 39% buy ratings versus 55% hold recommendations.